Cartesian Therapeutics, Inc. - Common Stock (NQ:RNAC)

6.170 +0.100 (+1.65%)

Streaming Delayed Price Updated: 12:31 PM EDT, Mar 25, 2026 Add to My Watchlist

Price and Volume

Volume	69,287
Open	6.210
Bid (Size)	6.160 (100)
Ask (Size)	6.200 (300)
Prev. Close	6.070
Today's Range	6.150 - 6.400
52wk Range	5.980 - 16.62
Shares Outstanding	115,079,292
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Cartesian Pauses Lupus And Multiple Myeloma Studies As It Shifts Development Focus ↗

November 14, 2025

Cartesian Therapeutics shared initial data from Phase 2 trial of Descartes-08, showing potential for treating systemic lupus erythematosus.

Via Benzinga

Nvidia To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday ↗

November 14, 2025

Via Benzinga

Performance

YTD	-8.7%	-8.7%
1 Month	-11.6%	-11.6%
3 Month	-4.0%	-4.0%
6 Month	-37.1%	-37.1%
1 Year	-61.3%	-61.3%

More News

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 19, 2025

Via Benzinga

Cartesian (RNAC) Q2 Revenue Drops 99% ↗

August 07, 2025

Via The Motley Fool

AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate ↗

July 24, 2025

Via Benzinga

With Trials In Motion, Cash To 2027, Can Kyverna's Next Data Drop Turn The Stock Around? ↗

May 27, 2025

Via Benzinga

US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert ↗

April 09, 2025

Via Benzinga

Why Venus Concept Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket ↗

April 09, 2025

Via Benzinga

Cartesian Therapeutics Reports Strong 12-Month Data For Lead Cell Therapy In Myasthenia Gravis Patients ↗

April 08, 2025

Via Benzinga

Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket ↗

April 04, 2025

Via Benzinga

Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases ↗

September 25, 2024

Via Investor's Business Daily

RNAC Stock Earnings: Cartesian Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

Via InvestorPlace

Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 05, 2024

Via Benzinga

Cartesian Therapeutics Plummets On 'Watershed Moment' For CAR-T Drugs ↗

July 02, 2024

Via Investor's Business Daily

Cartesian's Autoimmune Disorder Candidate Hits Primary Goal In Mid-Stage Study, Announces Equity Raise Of $130M ↗

July 02, 2024

Via Benzinga

RNAC Stock Earnings: Cartesian Therapeutics Misses EPS, Beats Revenue for Q1 2024 ↗

May 08, 2024

Via InvestorPlace

Cartesian Therapeutics Announces New Employment Inducement Grants

May 06, 2024

From Cartesian Therapeutics, Inc.

Via Business Wire

Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 23, 2024

Via Benzinga

HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday ↗

April 23, 2024

Via Benzinga

Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting

April 22, 2024

From Cartesian Therapeutics, Inc.

Via Business Wire

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 16, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 15, 2024

Via Benzinga

Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy ↗

April 10, 2024

Via Benzinga

Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

April 04, 2024

From Cartesian Therapeutics, Inc.

Via Business Wire

Frequently Asked Questions

Is Cartesian Therapeutics, Inc. - Common Stock publicly traded?

Yes, Cartesian Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Cartesian Therapeutics, Inc. - Common Stock trade on?

Cartesian Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Cartesian Therapeutics, Inc. - Common Stock?

The ticker symbol for Cartesian Therapeutics, Inc. - Common Stock is RNAC on the Nasdaq Stock Market

What is the current price of Cartesian Therapeutics, Inc. - Common Stock?

The current price of Cartesian Therapeutics, Inc. - Common Stock is 6.170

When was Cartesian Therapeutics, Inc. - Common Stock last traded?

The last trade of Cartesian Therapeutics, Inc. - Common Stock was at 03/25/26 12:31 PM ET

What is the market capitalization of Cartesian Therapeutics, Inc. - Common Stock?

The market capitalization of Cartesian Therapeutics, Inc. - Common Stock is 710.04M

How many shares of Cartesian Therapeutics, Inc. - Common Stock are outstanding?

Cartesian Therapeutics, Inc. - Common Stock has 710M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.